Sotabase

Career

· Senior Research Associate, Newcastle University2018–
· Doctor of Philosophy, Newcastle University2013–2018
· MSc Health Economics, University of York2012–2013
· BA Economics, Newcastle University2008–2011

Publications (68)

Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
Cochrane Database of Systematic Reviews · 2021
113
cited
The impact of New Labour’s English health inequalities strategy on geographical inequalities in infant mortality: a time-trend analysis
Journal of Epidemiology and Community Health · 2019
49
cited
An examination of trends in antibiotic prescribing in primary care and the association with area-level deprivation in England
BMC Public Health · 2020
36
cited
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
Cochrane Database of Systematic Reviews · 2020
29
cited
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review
Neuropathology and Applied Neurobiology · 2021
18
cited
Health for Wealth : Building a Healthier Northern Powerhouse for UK Productivity
2018
15
cited
Measuring Weight-Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test-Retest Reliability of the WAItE.
Value in Health · 2019
11
cited
Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT.
Health Technology Assessment · 2022
11
cited
Estimating CHU-9D Utility Scores from the WAItE: A Mapping Algorithm for Economic Evaluation.
Value in Health · 2019
10
cited
Interventions to reduce the time to diagnosis of brain tumours.
Cochrane Database of Systematic Reviews · 2020
9
cited
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
Cochrane Database of Systematic Reviews · 2021
7
cited
Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT
2020
7
cited
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
PharmacoEconomics (Auckland) · 2023
6
cited
Differences in health-related quality of life between the Roma community and the general population in Romania
Journal of Patient-Reported Outcomes · 2022
5
cited
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom
PLoS ONE · 2024
5
cited
Treatment options for recurrent glioblastoma: a network meta-analysis
Cochrane Database of Systematic Reviews · 2020
5
cited
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Cochrane Database of Systematic Reviews · 2022
4
cited
Developing a preference-based measure for weight-specific health-related quality of life in adolescence: the WAItE UK valuation study protocol
BMJ Open · 2021
3
cited
OP18 Evaluating the impact of the english health inequalities strategy on socioeconomic inequalities in the regional infant mortality rate
Oral presentations · 2018
3
cited
Evaluating high-cost technologies – no need to throw the baby out with the bathwater
Expert review of pharmacoeconomics & outcomes research · 2023
2
cited
Sotabase
Dr. Tomos Robinson | Researcher Profile | Sotabase | Sotabase